Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Its not a trust issue. Only one person at OWC is left of the management at that time. I am waiting to find out through Jeffee's testimony, who at OWC approved the removal of the restriction. Not yet sure how that connection will affect the company's liability, but that connection will be made. No permanent immunity from prosecution was in any of the paper work I read.
Are you saying the the SEC investigation into the OWCP share selling scheme is great news - if so I completely agree.
It is fantastic news - for those that read the SEC complaint it was obvious that OWCP helped orchestrate the pump and dump and Friedland was part of the scam from the beginning.
IG
Ziv couldn't approve the removal of the restrictive legend - the question is who hired a disbarred attorney to write the 144 Opinion Letter.
The SEC says that OWCP supplied the 144 Opinion Letter for Friedland.
IG
To me its a DONE DEAL as for TRUSTING OWC Pharmaceutical there rating just went to A++.
If there was anything not good they would have NEVER let OWC Pharmaceutical put out there PR of just how clean they are !
THIS IS HUGE NEW FANTASTIC NEWS WE JUST GOT THE GREEN LIGHT FROM THE U.S.GOVERNMENT!
Mods please sticky this post in IBOX
GOING UP, UP, UP, UP ..... and UP:
If we continue this 6M per day volume we will go up so fast. We won't need Jeffry Friedland to pump this up, and it won't matter who tries to push it down. OWCP is a highly professional corporation with great products about to hit the markets. Weak hands are finally gone and now come the chasers and when the chasers come the pps goes up. Won't be long before trips ---> $1.11, $2.22, $3.33, $4.44, $5.55, $6.66, .... and then eventually quads $11.11, $22.22, $33.33,.....
GO OWCP $$$$$$$$ IT'S GO TIME! $$$$$$$$$$$
It always should make you feel better to bring up stuff that has NOTHING to do with what I posted. None of them were with the company when this crap occurred. Keep convicing yourself that that will affect everything in the Friedland caper.
LOL! I love it. None of this gets rid of the New Hire Scientists and Nasdaq Chairman. Go Get em. Clean it up... None the less, company is in better hands and continues to get better... What's attracting the TALENT?
ONLY thing that would make me discontinue accumulation would be A HIRSCH or ZEEVI Issue... PERIOD... Because MMJ is coming HUUUUUUGGGGGGGGEE
And Israel is First to the Punch! No Dilution in 1yr+
The complaint stated that OWCP supplied the fraudulent documents to Friedland - not that Friedland created the documents.
Being on the advisory board - unless it is a typical pinky incestuous relationship between the insiders.
We know that Friedland was part of OWCP from the beginning - we know the company provided him fraudulent documents from a disbarred attorney to remove the restrictive legend so he could deposit the certs in various accounts.
"OWC provided an attorney opinion letter to OWC’s transfer agent from a disbarred attorney in connection with the issuance of OWC’s stock to Global."
The SEC clearly states that OWCP provided the opinion letter.
Since the TA is paid by OWCP - they would have less reason to question the Veracity of the documents.
There isn't any question that OWCP was heavily involved in the pump and dump.
Hence - the SEC is continuing the investigation.
IG
YES IT DOES THE BEST GIFT IN THE WORLD !!
THE SEC DID OWC PHARMACEUTICAL A HUGE FAVOR THEY PROVED TO THE WORLD OWC PHARMACEUTICAL IS NO SCAM, IS THE REAL DEAL, AND THIS NEWS ALONE IS WORTH WELL OVER A $1.00 JUST ON THAT.
NOW WITH ANY GOOD NEWS OWCP WILL GO TO MULTIPLE DOLLARS IN A SNAP OF A FINGER. NOW TRULY IS THE TIME TO LOAD THE BOAT AS THE U.S. GOVERNMENT JUST GAVE OWC PHARMACEUTICAL THE GREEN LIGHT!!!!!
I AM BUYING MORE TOMMOROW BECAUSE HOW MANY COMPANIES GET THE GREEN LIGHT FROM THE U.S.GOVERNMENT!
CHERRY
Not so fast, its early. The screws havent even been tightened yet on Jeffee. Someone at OWC approved the removal of restriction on the shares. TA had to contact them for approval on close to 5% of the O/S. They DONT make that call alone, liability is too great not to make a simple call or email. Not sure what the connection will mean, stay tuned.
With luck, we'll eventually learn the whole story.
I think there are 3 people outside of the TA that know what happened. Those 3 are Jeffee, Mordechai and Ziv. I think Jeffee knows a lot to be revealed, Ziv did it and Mordechai fired him for it. The question is, What will Jeffee reveal, and what problem will the company have if Ziv did release those shares?
Only question is why didn’t Owcp get rid of him months ago. They didn’t just find out about this yesterday.
Thanks for the prediction Camelot
Then maybe the TA is culpable. I just don't think this is over.......
Dont get too excited. It was a bounce off a knee jerk reaction to the Friedland caper. This stock has been trending lower and lower since the Boca presentation. Once it hits its new plateau, there it will remain in a small range until real activity, WITH REVENUE, starts in 6 months to a year.
yes sir but mines always take a lot of time to drill for that gold we are now back on the right path for a rebound up
should be I would settle for .295
It may be that Ziv approved the removal of the restriction from Friedland shares. And that could be the reason he was fired. It was only about a month or so later that he was canned.
could jeff f. have authorized it as an owcp board member? it was his company that sold the shares, maybe the TA didnt put the peices together?
Yes this is Fantastic News
Can a MOD STICKY THIS IN IBOX this ZERO DILUTION IS HUGE FOR US & OWC PHARMACEUTICAL BEING A 100% HONEST COMPANY!
Item 8.01. Other Events.
OWC Pharmaceutical Research Corp. (the “Registrant”) is filing this Form 8-K to report the resignation of Mr. Jeffrey Friedland (“Mr. Friedland”) as a member of the Registrant’s Advisory Board, effective immediately. A copy of Mr. Friedland’s letter of resignation is attached as exhibit 17.5 to this Form 8-K.
The Registrant has been made aware of the fact that the United States Securities and Exchange Commission (the “SEC”) has commenced a civil injunctive action against Mr. Friedland and two related entities (the “Friedland Defendants”) by the filing of a complaint in the United States District Court for the District of Colorado. The SEC alleges in the complaint that the Friedland Defendants “engaged in a nearly $7 million securities fraud scheme to conceal the nature of [Mr. Friedland’s] interest in . . . OWC Pharmaceutical Research Corp. (“OWC”) to allow him to unload his considerable holdings in OWC stock into the marked that he helped to artificially inflate.”
The Registrant has not been named as a party to the pending SEC action nor is the Registrant alleged to have been a party to nor had any knowledge of the purported scheme by the Friedland Defendants.
The Registrant is aware that Mr. Friedland, through one of his entities, was an early investor in the Registrant, having purchase more than 1.3 million shares of the Registrant’s common stock in 2014 in a private placement. In addition, in February 2016, Mr. Friedland was issued an additional 5.1 million shares through another of his entities (both of which are Friedland Defendants) as compensation for a two-year consulting agreement with the Registrant which agreement expired by its terms in February 2018.
The Registrant did not receive any of the proceeds from the sale by the Friedland Defendants of the OWC shares nor did the Registrant benefit by the alleged scheme by the Friedland Defendants. The registrant with its legal advisors continues to consider additional actions if and so required.
Item 9.01 Financial Statements and Exhibits.
(a) The following documents are filed as exhibits to this report on Form 8-K or incorporated by reference herein. Any document incorporated by reference is identified by a parenthetical reference to the SEC filing that included such document.
Exhibit No. Description
17.5 Letter of Resignation of Jeffrey Friedland dated March 5, 2018, filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OWC Pharmaceutical Research Corp.
By: /s/ Mordechai Bignitz
Name: Mordechai Bignitz
Title: Chief Executive Officer
Date: March 8, 2018
https://ih.advfn.com/p.php?pid=nmona&article=76897413&symbol=OWCP
https://www.otcmarkets.com/stock/OWCP/security
Zero dilution
Read this over and over please until you understand it.
. As we have stated in our 8-K filing of today, we are neither a party to the pending SEC action against a former adviser to the Company, nor is the Company alleged to have been a party to nor had any knowledge of the purported scheme by the former adviser, who is the subject of the SEC action.
You see, you can't have an ongoing investigation into someone who has never been charged.... OWCP
I would say it is the TA. This country is so full of crooks and liars that nothing surprises me anymore.
Well see him on an episodes of American Greed!!
I've read that already.... it's ongoing against Frieland, not the company.
Who authorized an investor then consultant to interact with the TA.
Either the company or TA is complicit!
Knowing the laws and rules makes my question very simple.
I'm a disbarred attorney.
Give me a call in the morning.
There has been no news on funding....they gagged the T/A....and VERT and PUMA have been on the ask for months.
Hmmmmm.....I 'suspect' the 2017 funding came from a lot of new shares.
If the company doesn't release the OS and AS to anyone who calls that is a sign the company is diluting.
When VERT has been on the ask for months you can be SURE they're diluting.
That is a fact so Glad I did not buy his stock that when they are all free trading on the same day the pps will crash with investors all trying to get out. I feel bad for the few longs in OWC that brought his stock.:(
Im sure some investors have acquired hundreds of thousands of shares over the past 2 trading days. Id be curious to know which individual or group bought the most.
Now i know the ideal play would have been to invest in a canadian LP last august. Cashed out in january and waited for this SEC investigation to come out to invest in owcp this morning. But of course that'd be impossible to know! Kinda like wishing you invested in apple or amazon at the very start.
The SEC’s investigation is ongoing. That's like the IRS stating paying taxes are 'Voluntary Compliance'. It's an oxymoron. So is 'The SEC’s investigation is ongoing."
Of course they will state that after a fresh new discovery. Maybe in several months they will send out a Release to this matter. But not yet. Too much activity to close the books.
"YW. I still have a problem how a supposedly legit company/SEC filer had the carpet pulled out from under them by a "consultant." I will stay on top of this one. "
How so..the company is just fine....nice try...
I believe the time to cheer is down the road.................
Or not.
Yes. Friedland's goose is cooked. And some of his assets are frozen, which surely doesn't make him happy.
Looks like OWCP hurt the feelings of some posters by closing GREEN today :)
Who authorized the TA to accept his ability to submit documentation? Or is the TA complicit?
Stretching the facts? It is more like flat out lying :)
YW. I still have a problem how a supposedly legit company/SEC filer had the carpet pulled out from under them by a "consultant." I will stay on top of this one.
Dude do you really think people on this board are stupid and can’t understand a document they read? We all read the SEC report and it states multiple times that “FRIEDLAND PROVIDED THE LETTER TO ILLEGALLY REMOVE THE RESTRICTIONS” not OWCP
Stop making $hit up!
WRONG again! OWC didn't supply information/documents in January 2017. Jefferey Friedland did (according to the SEC).
43. On or about January 14, 2017, Friedland submitted a request to OWC’s transfer agent to reissue Global’s 5,134,375 shares of OWC stock to Lane 6552 LLC and remove the restricted legend from the securities.
44. Restricted securities are securities acquired in unregistered, private sales from the issuing company or from an affiliate of the issuer. Investors typically receive restricted securities through private placement offerings, Regulation D offerings, employee stock benefit plans, as compensation for professional services, or in exchange for providing “seed money” or start-up capital to the company. When investors acquire restricted securities, they must find an exemption from the SEC’s registration requirements to sell the securities in a public marketplace.
45. In order to sell his restricted shares in the public marketplace, Friedland needed to have OWC’s transfer agent remove the restricted legend on Global’s 5,134,375 shares.
46. Friedland provided the transfer agent with a purported attorney opinion letter that included inaccurate information about Global’s acquisition of OWC stock and misleading information about the connection between Friedland, Global, and Lane 6552. The letter was signed by a disbarred attorney.
"Why do you think OWCP supplied fraudulent documents to Friedland to remove the restrictive legend so he could deposit the certs in different accounts. "
Again...stretching the facts....not as stated in the SEC complaint at all...
It is clarified that OWCP provided document(s) but that they were not the one's that provided the information contained in said documents..
Of course you jump on this and fail to grasp the truth..
as provided directly from the SEC document in my previous post.
LOL...I have to give you credit..you are relentless...but anyone with a grain of intelligence can see through all of your half truths and muses and misrepresentation of facts.
I think the SEC might be interested in hearing about you.
MUST READ
OTC DISCLOSURE & NEWS SERVICE
OWC Pharmaceutical Research Corp. Issues Chairman's Statement to ShareholdersPress Release | 03/08/2018
OWC Pharmaceutical Research Corp. Issues Chairman's Statement to Shareholders
PR Newswire
PETACH TIKVA, Israel, March 8, 2018
PETACH TIKVA, Israel, March 8, 2018 /PRNewswire/ -- OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today issued a chairman's statement to shareholders.
OWC Logo
In the light of recent events, and the numerous communications we have received from shareholders, I would like to address this statement to the Shareholders of OWCP (the "Company").
The Company is committed to building a leadership position in the medical cannabis market and to our mission of improving patients' lives through the development of new solutions, products and devices derived from and delivery mechanisms for the use of medical cannabis.
We have recruited a highly skilled management team with multi-year experience in medical cannabis, pharmaceutical development, corporate management and capital markets.
As we have stated in our 8-K filing of today, we are neither a party to the pending SEC action against a former adviser to the Company, nor is the Company alleged to have been a party to nor had any knowledge of the purported scheme by the former adviser, who is the subject of the SEC action.
The Company's management is committed to and focused on our development programs which are continuing as per plan. These include inter alia, our current safety trial for our cannabis cream; the approval processes to initiate a safety trial for our oral disintegrating tablet and additional pipeline projects.
As a management team, we are committed to building value for our shareholders though professional, ethical and strategic management of a technology platform that we believe will bring improved health and quality of life to millions of patients around the world. We have recently announced the addition of our new Chief Scientific Officer and we continue to develop the resources we believe will bolster our endeavors in creating a great company.
Yours sincerely,
Dr. Stanley Hirsch
Chairman of the Board
About OWC Pharmaceutical Research Corp.
OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., (collectively 'OWC' or the 'Company') conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines.
OWCP is also developing unique delivery systems for the effective delivery and dosage of medical cannabis. All OWCP research is conducted at leading Israeli hospitals and scientific institutions and led by internationally renowned investigators. The Company's Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids and cannabis-based products for the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.
For more information visit: http://www.owcpharma.com/.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, filing patent applications, product development, and business strategy. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in OWC Pharmaceutical Research Corp. (OTCQB: OWCP) periodic reports filed from time-to-time with the Securities and Exchange Commission.
Contact Information::
Mordechai Bignitz , Chief Executive Officer – OWC Pharmaceutical Research Corp.
Email: Mordechai.Bignitz@owcpharma.com
Tel: +972-(0)3-7582659
Cision View original content:http://www.prnewswire.com/news-releases/owc-pharmaceutical-research-corp-issues-chairmans-statement-to-shareholders-300610781.html
SOURCE OWC Pharmaceutical Research Corp.
But,..based on what has occurred the transfer agent didn't check.
Then it's entirely possible the TA will also get into trouble. Not to mention the disbarred attorney.
If nobody's commented on it yet, the SEC finally got round to posting the Friedland suit on its website:
https://www.sec.gov/news/press-release/2018-34
Note these parts:
The investigation has been conducted by Michael T. Grimes, Keith O’Donnell, William Connolly, Shipra G. Wells, and Josh Felker, and supervised by Melissa R. Hodgman. Christian Schultz and Timothy Halloran will lead the SEC’s litigation under the supervision of Fred Block. The SEC appreciates the assistance of Financial Industry Regulatory Authority.
The SEC’s investigation is ongoing.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |